Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results 2024-01-31 05:30
Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study 2024-01-30 22:00
XtalPi Unveils Ailux: A New Chapter in AI-Powered Biologics Discovery 2024-01-30 21:00
Singleron launches the AccuraSCOPE® Single Cell Transcriptome 2024-01-30 18:05
Results of the Phase III INSPIRE Study on Qilu Pharmaceutical's Iruplinalkib Published in the Journal of Thoracic Oncology 2024-01-30 16:45
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD 2024-01-30 16:32
Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation 2024-01-29 21:30
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma. 2024-01-29 21:08
Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders 2024-01-29 21:00
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial 2024-01-29 21:00
Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU 2024-01-29 16:17
Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide 2024-01-26 20:08
FDA clears RF Medical's MYGEN™ M-3004 and MYOBLATE™ Radiofrequency Ablation System 2024-01-26 15:26
AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site 2024-01-26 08:30
First International Shipment of HANSIZHUANG Launched 2024-01-25 21:41
First International Shipment of HANSIZHUANG 2024-01-25 20:45
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World 2024-01-25 18:38
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World 2024-01-25 18:00
Asieris will Present For the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU 2024-01-25 16:56
Alphamab Oncology and 3DMedicines Entered into a Licensing Agreement with Glenmark for KN035 2024-01-25 10:40
1 54 55 56 57 58 413